Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
22 /100
LOW RISK
Score updated Aug 28, 2026

LGND — Ligand Pharmaceuticals Incorporated Dilution Risk Tracker

Track LGND dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LGND — Get alerts when the score changes →

As of August 28, 2026, Ligand Pharmaceuticals Incorporated (LGND) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. Ligand Pharmaceuticals Incorporated has a market capitalization of $4.65B, 19.94M shares outstanding, 360 institutional holders tracked. Stored dilution-related fields include 3.26M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway
📊 Float Risk
25
⚠️ Warrant Exposure
50
🔄 Convertible Debt
35

Dilution Forecast

Watch
Minor dilution signals detected
model est. 17%
📜 Warrant Exercise model 25%
• Significant warrants: 16% of shares outstanding
🔁 Convertible Conversion model 15%
• Convertible debt present: 9.9% potential dilution
🔔 Track LGND — Get forecast alerts →

Market Data

Market Cap$4.65B
Shares Outstanding19.94M
Float19.57M
Cash$1.36B
Debt$1.13B
Short InterestN/A

Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
360 institutional holders · 24.14M shares
#1 BlackRock, Inc. 2.96M shares
#2 JANUS HENDERSON GROUP PLC 2.02M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.70M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.17M
Days to Cover7.4
% of Float11.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2023-12-31
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LGND Dilution Snapshot

Ligand Pharmaceuticals Incorporated (LGND) has a DilutionScore of 22/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LGND Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LGND — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LGND
LGND FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.